$RMD
RESMED INC

2024 Q3 Form 10-K Financial Statement

#000094381924000013 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2024
Revenue $1.225B $1.223B $4.685B
YoY Change 11.08% 9.01% 10.95%
Cost Of Revenue $507.3M $507.7M $2.030B
YoY Change 1.0% 0.59% 8.71%
Gross Profit $717.2M $715.5M $2.655B
YoY Change 19.52% 15.9% 12.72%
Gross Profit Margin 58.57% 58.5% 56.67%
Selling, General & Admin $239.0M $242.2M $917.1M
YoY Change 7.23% 0.62% 4.94%
% of Gross Profit 33.32% 33.85% 34.54%
Research & Development $79.52M $80.86M $307.5M
YoY Change 5.04% 3.48% 6.91%
% of Gross Profit 11.09% 11.3% 11.58%
Depreciation & Amortization $44.73M $43.68M $176.9M
YoY Change -0.45% -6.59% 7.09%
% of Gross Profit 6.24% 6.1% 6.66%
Operating Expenses $329.9M $334.3M $1.335B
YoY Change 6.06% 0.95% 9.12%
Operating Profit $387.3M $381.2M $1.320B
YoY Change 34.02% 33.18% 16.61%
Interest Expense -$1.661M -$20.53M -$45.71M
YoY Change -91.46% 9.45% 2.2%
% of Operating Profit -0.43% -5.38% -3.46%
Other Income/Expense, Net -$3.815M -$2.957M -$55.10M
YoY Change -77.3% -4947.54% 82.39%
Pretax Income $383.5M $357.7M $1.265B
YoY Change 40.89% 29.24% 14.81%
Income Tax $72.14M $65.50M $243.8M
% Of Pretax Income 18.81% 18.31% 19.28%
Net Earnings $311.4M $292.2M $1.021B
YoY Change 41.9% 27.25% 13.75%
Net Earnings / Revenue 25.43% 23.89% 21.79%
Basic Earnings Per Share $2.12 $6.94
Diluted Earnings Per Share $2.11 $1.98 $6.92
COMMON SHARES
Basic Shares Outstanding 146.9M shares 146.9M shares 147.0M shares
Diluted Shares Outstanding 147.6M shares 147.6M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2024
SHORT-TERM ASSETS
Cash & Short-Term Investments $426.4M $238.4M $238.4M
YoY Change 103.9% 4.59% 4.59%
Cash & Equivalents $426.4M $238.4M $238.4M
Short-Term Investments
Other Short-Term Assets $213.0M $180.0M $421.7M
YoY Change 31.75% 0.05% 3.98%
Inventory $918.0M $822.3M $822.3M
Prepaid Expenses
Receivables $811.2M $837.3M $875.5M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.641B $2.358B $2.358B
YoY Change 14.6% -0.43% -0.43%
LONG-TERM ASSETS
Property, Plant & Equipment $560.2M $548.0M $699.1M
YoY Change 4.91% 1.89% 5.01%
Goodwill $2.886B $2.842B
YoY Change 2.63% 2.59%
Intangibles
YoY Change
Long-Term Investments $69.29M $65.46M $65.46M
YoY Change 11.46% 0.15% 0.15%
Other Assets $278.9M $284.0M $403.7M
YoY Change 5.18% 8.21% 26.15%
Total Long-Term Assets $4.581B $4.515B $4.515B
YoY Change 3.27% 2.98% 2.98%
TOTAL ASSETS
Total Short-Term Assets $2.641B $2.358B $2.358B
Total Long-Term Assets $4.581B $4.515B $4.515B
Total Assets $7.222B $6.872B $6.872B
YoY Change 7.15% 1.79% 1.79%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $249.3M $237.7M $237.7M
YoY Change 40.8% 57.69% 57.69%
Accrued Expenses $365.7M $377.7M $403.0M
YoY Change 5.02% 3.29% 3.97%
Deferred Revenue $157.2M $152.6M
YoY Change 7.14% 10.49%
Short-Term Debt $9.896M $9.900M $0.00
YoY Change -0.09% -0.02%
Long-Term Debt Due $9.896M $9.900M $9.900M
YoY Change -0.09% -0.02% -0.02%
Total Short-Term Liabilities $904.1M $910.7M $910.7M
YoY Change 17.29% 20.05% 20.05%
LONG-TERM LIABILITIES
Long-Term Debt $667.6M $697.3M $697.3M
YoY Change -50.61% -51.28% -51.28%
Other Long-Term Liabilities $83.27M $42.26M $321.0M
YoY Change 142.57% -38.01% -5.96%
Total Long-Term Liabilities $1.123B $1.098B $1.018B
YoY Change -34.68% -41.09% -42.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $904.1M $910.7M $910.7M
Total Long-Term Liabilities $1.123B $1.098B $1.018B
Total Liabilities $2.027B $2.008B $2.008B
YoY Change -18.59% -23.4% -23.4%
SHAREHOLDERS EQUITY
Retained Earnings $5.225B $4.992B
YoY Change 18.7% 17.37%
Common Stock $1.925B $1.897B
YoY Change 7.44% 7.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $5.195B $4.864B $4.864B
YoY Change
Total Liabilities & Shareholders Equity $7.222B $6.872B $6.872B
YoY Change 7.15% 1.79% 1.79%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2024
OPERATING ACTIVITIES
Net Income $311.4M $292.2M $1.021B
YoY Change 41.9% 27.25% 13.75%
Depreciation, Depletion And Amortization $44.73M $43.68M $176.9M
YoY Change -0.45% -6.59% 7.09%
Cash From Operating Activities $325.5M $440.1M $1.401B
YoY Change 13.71% 85.36% 102.11%
INVESTING ACTIVITIES
Capital Expenditures $17.84M $26.32M $99.46M
YoY Change -40.6% -32.04% -16.89%
Acquisitions $0.00 $133.5M
YoY Change -100.0% -86.82%
Other Investing Activities $21.75M -$20.19M -$154.9M
YoY Change -120.12% 159.16% -84.9%
Cash From Investing Activities $2.146M -$46.51M -$269.8M
YoY Change -101.44% -0.03% -76.74%
FINANCING ACTIVITIES
Cash Dividend Paid $77.89M $282.3M
YoY Change 10.33% 9.31%
Common Stock Issuance & Retirement, Net $96.92M
YoY Change 97.22%
Debt Paid & Issued, Net $30.00M $835.0M
YoY Change -83.78% 106.17%
Cash From Financing Activities -$150.8M -393.3M -$1.119B
YoY Change -0.25% 108.54% -364.69%
NET CHANGE
Cash From Operating Activities $325.5M 440.1M $1.401B
Cash From Investing Activities $2.146M -46.51M -$269.8M
Cash From Financing Activities -$150.8M -393.3M -$1.119B
Net Change In Cash $188.0M 322.0K $10.47M
YoY Change -1100.48% -86.13% -122.85%
FREE CASH FLOW
Cash From Operating Activities $325.5M $440.1M $1.401B
Capital Expenditures $17.84M $26.32M $99.46M
Free Cash Flow $307.7M $413.8M $1.302B
YoY Change 20.08% 108.25% 126.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024 dei Document Annual Report
DocumentAnnualReport
true
CY2024 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2024 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2024 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2024 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024 dei Entity Small Business
EntitySmallBusiness
false
CY2024 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
238361000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
21132000 usd
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
837275000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
822250000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459833000 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2357719000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548025000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
151121000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
2842055000 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
203569000 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
284001000 usd
CY2024Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
4514675000 usd
CY2024Q2 us-gaap Assets
Assets
6872394000 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
237728000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
377678000 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
25278000 usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
152554000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
107517000 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9900000 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
910655000 usd
CY2024Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
137343000 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
79339000 usd
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
42257000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
697313000 usd
CY2024Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
0 usd
CY2024Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1097696000 usd
CY2024Q2 us-gaap Liabilities
Liabilities
2008351000 usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
588000 usd
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1896604000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4991647000 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
42664067 shares
CY2024Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1773267000 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-251529000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4864043000 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6872394000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4685297000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4222993000 usd
CY2024 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1997031000 usd
CY2023 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1836935000 usd
CY2024 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
917136000 usd
CY2024 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
307525000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
287642000 usd
CY2024 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
10949000 usd
CY2024 us-gaap Operating Expenses
OperatingExpenses
1335410000 usd
CY2024 us-gaap Operating Income Loss
OperatingIncomeLoss
1319893000 usd
CY2024 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1848000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7265000 usd
CY2024 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-4045000 usd
CY2023 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
9922000 usd
CY2024 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 usd
CY2023 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
20227000 usd
CY2024 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3494000 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5712000 usd
CY2024 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55095000 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-30207000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1264798000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1101664000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
243847000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
204108000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1020951000 usd
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.94
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.92
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.09
CY2024 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.92
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.76
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147021000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146765000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147550000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147455000 shares
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1020951000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
897556000 usd
CY2024 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
31743000 usd
CY2023 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-35596000 usd
CY2024 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10744000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
75815000 usd
CY2024 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1041950000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
937775000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.035
CY2024 us-gaap Operating Lease Payments
OperatingLeasePayments
30573000 usd
CY2024 rmd Operating Lease Income
OperatingLeaseIncome
92900000 usd
CY2023 rmd Operating Lease Income
OperatingLeaseIncome
88600000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
4051000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
8278000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
243847000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
204108000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
181046000 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
203569000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
132974000 usd
CY2024Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
79339000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
90650000 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
124230000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
35336000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
34314000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
9271000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
6051000 usd
CY2024Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
15602000 usd
CY2023Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
13212000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
6112000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
5348000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
6103000 usd
CY2024Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
23455000 usd
CY2023Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22387000 usd
CY2024Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
5587000 usd
CY2023Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
917000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
11538000 usd
CY2023Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8670000 usd
CY2024Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
28030000 usd
CY2023Q2 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
23908000 usd
CY2024Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
125411000 usd
CY2023Q2 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
111704000 usd
CY2024Q2 rmd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
25602000 usd
CY2023Q2 rmd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
21347000 usd
CY2024Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
56324000 usd
CY2023Q2 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
27666000 usd
CY2024 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
49600000 usd
CY2024 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.34
CY2023 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
40500000 usd
CY2023 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.27
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176870000 usd
CY2024 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
32963000 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
30396000 usd
CY2024 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2029994000 usd
CY2023 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1867331000 usd
CY2022 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1553816000 usd
CY2024 us-gaap Gross Profit
GrossProfit
2655303000 usd
CY2022 us-gaap Gross Profit
GrossProfit
2024311000 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
874003000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
737508000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
253575000 usd
CY2024 dei Amendment Flag
AmendmentFlag
false
CY2024 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2024 dei Entity Central Index Key
EntityCentralIndexKey
0000943819
CY2024 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024 dei Document Transition Report
DocumentTransitionReport
false
CY2024 us-gaap Impairment Of Intangible Asset Finite Lived Statement Of Income Or Comprehensive Income Extensible Enumeration
ImpairmentOfIntangibleAssetFiniteLivedStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2024#RestructuringCharges
CY2023Q2 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q2 us-gaap Derivative Asset Current Statement Of Financial Position Extensible Enumeration
DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q2 us-gaap Derivative Asset Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent
CY2023Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Derivative Liability Noncurrent Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Derivative Liability Current Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent
CY2023Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2024Q2 us-gaap Derivative Liability Statement Of Financial Position Extensible Enumeration
DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent
CY2023Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024Q2 us-gaap Derivative Asset Statement Of Financial Position Extensible Enumeration
DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrent http://fasb.org/us-gaap/2024#PrepaidExpenseAndOtherAssetsCurrent
CY2024 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2024 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
25155017346 usd
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
146932119 shares
CY2024 dei Auditor Name
AuditorName
KPMG LLP
CY2024 dei Auditor Location
AuditorLocation
San Diego, CA
CY2024 dei Auditor Firm
AuditorFirmId
185
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227891000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23603000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
704909000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
998012000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
437018000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
2367830000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
537856000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127955000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2770299000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
485904000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
552341000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Other Assets Noncurrent
DeferredIncomeTaxesAndOtherAssetsNoncurrent
132974000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
262453000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
4383878000 usd
CY2023Q2 us-gaap Assets
Assets
6751708000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
150756000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
365660000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
21919000 usd
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
138072000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
72224000 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9902000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
758533000 usd
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
119186000 usd
CY2023Q2 us-gaap Deferred Income Taxes And Other Tax Liabilities Noncurrent
DeferredIncomeTaxesAndOtherTaxLiabilitiesNoncurrent
90650000 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
141444000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
116853000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
68166000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1431234000 usd
CY2023Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
37183000 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1863272000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2621805000 usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.004
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
189565112 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
146901045 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
188900583 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
147064349 shares
CY2023Q2 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
588000 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1772083000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4253016000 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
41836234 shares
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1623256000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-272528000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4129903000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6751708000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3578127000 usd
CY2022 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
1514166000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
39650000 usd
CY2023 us-gaap Gross Profit
GrossProfit
2355662000 usd
CY2024 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
46521000 usd
CY2023 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
42020000 usd
CY2022 rmd Amortization Of Acquired Intangible Assets1
AmortizationOfAcquiredIntangibleAssets1
31078000 usd
CY2024 us-gaap Restructuring Charges
RestructuringCharges
64228000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
9177000 usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1864000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1223791000 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1024025000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
1131871000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
1000286000 usd
CY2024 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-45708000 usd
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47379000 usd
CY2022 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-22312000 usd
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8486000 usd
CY2022 us-gaap Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
-12202000 usd
CY2022 us-gaap Gain On Business Interruption Insurance Recovery
GainOnBusinessInterruptionInsuranceRecovery
0 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3197000 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-39803000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
960483000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
181046000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
779437000 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.34
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.30
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.68
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146066000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147043000 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
779437000 usd
CY2022 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-119260000 usd
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
660177000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
2885679000 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11205000 usd
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-52406000 usd
CY2022 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36180000 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
65257000 usd
CY2022 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-119260000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
779437000 usd
CY2022 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.68
CY2022 us-gaap Dividends
Dividends
245341000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
3360751000 usd
CY2023 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9696000 usd
CY2023 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-30631000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
39446000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
71142000 usd
CY2023 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
40219000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
897556000 usd
CY2023 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.76
CY2023 us-gaap Dividends
Dividends
258276000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
4129903000 usd
CY2024 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13484000 usd
CY2024 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-8757000 usd
CY2024 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
39610000 usd
CY2024 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
150011000 usd
CY2024 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
80184000 usd
CY2024 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
20999000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1020951000 usd
CY2024 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.92
CY2024 us-gaap Dividends
Dividends
282320000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
4864043000 usd
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1020951000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
897556000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
779437000 usd
CY2024 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
176870000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165156000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
159609000 usd
CY2024 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
39339000 usd
CY2023 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32406000 usd
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
34232000 usd
CY2024 us-gaap Share Based Compensation
ShareBasedCompensation
80184000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
71142000 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
65257000 usd
CY2024 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-1848000 usd
CY2023 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-10138000 usd
CY2022 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-8486000 usd
CY2024 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-4045000 usd
CY2023 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
9922000 usd
CY2022 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-12202000 usd
CY2024 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
33239000 usd
CY2023 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
9177000 usd
CY2022 us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
0 usd
CY2024 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2023 us-gaap Insurance Recoveries
InsuranceRecoveries
20227000 usd
CY2022 us-gaap Insurance Recoveries
InsuranceRecoveries
0 usd
CY2024 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
134278000 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
106511000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-19346000 usd
CY2024 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-172203000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
248833000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
311681000 usd
CY2024 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
115213000 usd
CY2023 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
138125000 usd
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
168109000 usd
CY2024 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
122072000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
31342000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-247632000 usd
CY2024 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1401260000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
693299000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
351147000 usd
CY2024 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
99460000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
119672000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
134835000 usd
CY2024 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
15396000 usd
CY2023 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14328000 usd
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
21201000 usd
CY2024 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
133464000 usd
CY2023 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1012749000 usd
CY2022 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
42784000 usd
CY2024 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12765000 usd
CY2023 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
32229000 usd
CY2022 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
20724000 usd
CY2024 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1000000 usd
CY2023 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
3937000 usd
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
6802000 usd
CY2024 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
9699000 usd
CY2023 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
-15196000 usd
CY2022 us-gaap Payments For Proceeds From Derivative Instrument Investing Activities
PaymentsForProceedsFromDerivativeInstrumentInvestingActivities
17176000 usd
CY2024 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-269784000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1159845000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-229918000 usd
CY2024 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
53094000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
49142000 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47384000 usd
CY2024 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
8757000 usd
CY2023 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
30631000 usd
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52406000 usd
CY2024 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
150011000 usd
CY2023 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2024 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
1293000 usd
CY2023 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
2361000 usd
CY2022 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
CY2024 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
105000000 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
1070000000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
288000000 usd
CY2024 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
835000000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
405000000 usd
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
166000000 usd
CY2024 us-gaap Payments Of Dividends
PaymentsOfDividends
282320000 usd
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
258276000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
245341000 usd
CY2024 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1119287000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
422874000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-128363000 usd
CY2024 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1719000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2147000 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-14434000 usd
CY2024 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10470000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-45819000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-21568000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227891000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273710000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295278000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238361000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227891000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273710000 usd
CY2024 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
278400000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
216866000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
478120000 usd
CY2024 us-gaap Interest Paid Net
InterestPaidNet
45708000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
47379000 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
22312000 usd
CY2024 rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
46033000 usd
CY2023 rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
359730000 usd
CY2022 rmd Noncash Part Of Acquisition Fair Value Of Assets Acquired
NoncashPartOfAcquisitionFairValueOfAssetsAcquired
15648000 usd
CY2024 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
7696000 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
131765000 usd
CY2022 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
4672000 usd
CY2024 rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
92191000 usd
CY2023 rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
786990000 usd
CY2022 rmd Goodwill Acquired During Period Increase Decrease
GoodwillAcquiredDuringPeriodIncreaseDecrease
38953000 usd
CY2024 rmd Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination
0 usd
CY2023 rmd Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination
0 usd
CY2022 rmd Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Equity Interest In Acquiree Held Prior To Combination
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationEquityInterestInAcquireeHeldPriorToCombination
4078000 usd
CY2024 rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
-143000 usd
CY2023 rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
2542000 usd
CY2022 rmd Deferred Payment Obligations For Acquisitions
DeferredPaymentObligationsForAcquisitions
-3067000 usd
CY2024 rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
-4372000 usd
CY2023 rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
2387000 usd
CY2022 rmd Business Acquisition Contingent Consideration Recognized Liability
BusinessAcquisitionContingentConsiderationRecognizedLiability
0 usd
CY2024 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
134757000 usd
CY2023 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
1015110000 usd
CY2022 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
42784000 usd
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024 us-gaap Depreciation
Depreciation
88900000 usd
CY2023 us-gaap Depreciation
Depreciation
84700000 usd
CY2022 us-gaap Depreciation
Depreciation
81000000.0 usd
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
355570000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
459126000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2713000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3956000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
463967000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
534930000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
822250000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
998012000 usd
CY2024Q2 us-gaap Prepaid Taxes
PrepaidTaxes
107623000 usd
CY2023Q2 us-gaap Prepaid Taxes
PrepaidTaxes
114009000 usd
CY2024Q2 rmd Prepaid Inventory
PrepaidInventory
172198000 usd
CY2023Q2 rmd Prepaid Inventory
PrepaidInventory
143084000 usd
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
180012000 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
179925000 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
459833000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
437018000 usd
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1274992000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1205868000 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
726967000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
668012000 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
548025000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
537856000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
2770299000 usd
CY2024 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
92191000 usd
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-20435000 usd
CY2024Q2 us-gaap Goodwill
Goodwill
2842055000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
485904000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
552341000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
81975000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
76847000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
58023000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
49431000 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
43492000 usd
CY2024Q2 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
12026000 usd
CY2023Q2 rmd Marketable Equity Investments Fair Value
MarketableEquityInvestmentsFairValue
12423000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
73739000 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
68748000 usd
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
65462000 usd
CY2023Q2 us-gaap Equity Method Investments
EquityMethodInvestments
65366000 usd
CY2024Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
151227000 usd
CY2023Q2 rmd Equity Investments Total By Measurement Category
EquityInvestmentsTotalByMeasurementCategory
146537000 usd
CY2023Q2 rmd Equity Investments
EquityInvestments
146537000 usd
CY2024 rmd Additional Equity Investments
AdditionalEquityInvestments
12765000 usd
CY2024 rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
2315000 usd
CY2024 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
4963000 usd
CY2024 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-1000000 usd
CY2024 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1397000 usd
CY2024 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1848000 usd
CY2024 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-1182000 usd
CY2024Q2 rmd Equity Investments
EquityInvestments
151227000 usd
CY2022Q2 rmd Equity Investments
EquityInvestments
58375000 usd
CY2023 rmd Additional Equity Investments
AdditionalEquityInvestments
89462000 usd
CY2023 rmd Observable Price Adjustments On Non Marketable Equity Securities
ObservablePriceAdjustmentsOnNonMarketableEquitySecurities
12612000 usd
CY2023 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
4892000 usd
CY2023 us-gaap Equity Securities Fv Ni Realized Gain Loss
EquitySecuritiesFvNiRealizedGainLoss
3937000 usd
CY2023 us-gaap Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
-3937000 usd
CY2023 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-1735000 usd
CY2023 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7265000 usd
CY2023 us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
2873000 usd
CY2023 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
2853000 usd
CY2023Q2 rmd Equity Investments
EquityInvestments
146537000 usd
CY2024 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-4000000.0 usd
CY2023 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
6000000.0 usd
CY2022 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-16200000 usd
CY2024Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
35134000 usd
CY2023Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
27621000 usd
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
27143000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
26148000 usd
CY2024Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
27016000 usd
CY2023Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
23636000 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
223862000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
220785000 usd
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
6023000 usd
CY2023Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
9366000 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4654000 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
9558000 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
9206000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
9375000 usd
CY2024Q2 rmd Accrued Logistics And Occupancy Expenses Current
AccruedLogisticsAndOccupancyExpensesCurrent
17996000 usd
CY2023Q2 rmd Accrued Logistics And Occupancy Expenses Current
AccruedLogisticsAndOccupancyExpensesCurrent
16278000 usd
CY2024Q2 rmd Accrued Inventory In Transit
AccruedInventoryInTransit
8045000 usd
CY2023Q2 rmd Accrued Inventory In Transit
AccruedInventoryInTransit
10034000 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
18599000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
12859000 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
377678000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
365660000 usd
CY2024Q2 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2023Q2 rmd Short Term Debt Gross
ShortTermDebtGross
10000000 usd
CY2024Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
100000 usd
CY2023Q2 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
98000 usd
CY2024Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9900000 usd
CY2023Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
9902000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
700000000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1435000000 usd
CY2024Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
2687000 usd
CY2023Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
3766000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
697313000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1431234000 usd
CY2024Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
707213000 usd
CY2023Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1441136000 usd
CY2024 rmd Debt To Consolidated Ebitda Ratio
DebtToConsolidatedEbitdaRatio
3.50
CY2024 rmd Line Of Credit Facility Collateral Percentage Of The Company
LineOfCreditFacilityCollateralPercentageOfTheCompany
0.100
CY2024 us-gaap Operating Lease Cost
OperatingLeaseCost
40800000 usd
CY2023 us-gaap Operating Lease Cost
OperatingLeaseCost
33600000 usd
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
35300000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
197933000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
30767000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
26247000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
22570000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
20454000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
19089000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
78806000 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
31211000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
166722000 usd
CY2024Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y8M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y2M12D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.027
CY2023 us-gaap Operating Lease Payments
OperatingLeasePayments
29047000 usd
CY2024 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
54588000 usd
CY2023 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
16803000 usd
CY2022 rmd Operating Lease Income
OperatingLeaseIncome
90100000 usd
CY2014Q1 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
20000000.0 shares
CY2014Q1 srt Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
20000000.0 shares
CY2024 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
828000 shares
CY2024 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
150000000.0 usd
CY2023 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
CY2024Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
12100000 shares
CY1997Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000.0 shares
CY1997Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P7Y
CY2024Q2 rmd Reduction In Number Of Shares Of Common Stock Available For Issuance
ReductionInNumberOfSharesOfCommonStockAvailableForIssuance
2.8
CY2024 rmd Number Of Shares Given For Each Share Of Common Stock Delivered In Settlement Of All Other Awards
NumberOfSharesGivenForEachShareOfCommonStockDeliveredInSettlementOfAllOtherAwards
1 shares
CY2024Q2 rmd Maximum Number Of Shares Subject To Awards Granted
MaximumNumberOfSharesSubjectToAwardsGranted
3000000 shares
CY2024Q2 rmd Number Of Common Stock Granted
NumberOfCommonStockGranted
4500000 shares
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
51000000.0 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
66800000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
65500000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
881000 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
134.52
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
73000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
148.90
CY2024 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
166000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
81.76
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000 shares
CY2024 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
232.16
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
786000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
146.90
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y9M18D
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
633000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
136.06
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y1M6D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
778000 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
146.52
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y9M18D
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
17900000 usd
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
25400000 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
33700000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42900000 usd
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
39800000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
42700000 usd
CY2024 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
323000 shares
CY2023 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
220000 shares
CY2022 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
216000 shares
CY2024 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
80184000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
71142000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
65257000 usd
CY2024 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
15053000 usd
CY2023 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
24860000 usd
CY2022 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
29262000 usd
CY2024 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
65131000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
46282000 usd
CY2022 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
35995000 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
142400000 usd
CY2024 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y7M6D
CY2024 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
603859000 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
272104000 shares
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
67000000 shares
CY2024 us-gaap Net Income Loss
NetIncomeLoss
1020951000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
897556000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
779437000 usd
CY2024 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
147021000 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146765000 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
146066000 shares
CY2024 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
529000 shares
CY2023 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
690000 shares
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
977000 shares
CY2024 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147550000 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147455000 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
147043000 shares
CY2024 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.94
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
6.12
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.34
CY2024 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.92
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
6.09
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.30
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
181107000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
128589000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-85919000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1083691000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
973075000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
1046402000 usd
CY2024 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1264798000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1101664000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
960483000 usd
CY2024 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
57103000 usd
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
36631000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4376000 usd
CY2024 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17250000 usd
CY2023 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
14142000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
10700000 usd
CY2024 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
219372000 usd
CY2023 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
198767000 usd
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
177788000 usd
CY2024 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
293725000 usd
CY2023 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
249540000 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
192864000 usd
CY2024 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-22915000 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-21721000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-12612000 usd
CY2024 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-4632000 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2389000 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-2773000 usd
CY2024 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-22331000 usd
CY2023 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-21322000 usd
CY2022 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
3567000 usd
CY2024 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-49878000 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-45432000 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-11818000 usd
CY2024 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
243847000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
204108000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
181046000 usd
CY2024 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
265608000 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
231349000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
201701000 usd
CY2024 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
8609000 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
9448000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
5703000 usd
CY2024 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
27786000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
21481000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
17517000 usd
CY2024 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
849000 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-5007000 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
858000 usd
CY2024 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-15838000 usd
CY2023 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-3982000 usd
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-4384000 usd
CY2024 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
8293000 usd
CY2023 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
3988000 usd
CY2022 us-gaap Income Tax Reconciliation Tax Credits Foreign
IncomeTaxReconciliationTaxCreditsForeign
2299000 usd
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
4875000 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-6282000 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
-11294000 usd
CY2024 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
15823000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
42324000 usd
CY2024Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
5340000 usd
CY2024Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
3566000 usd
CY2023Q2 us-gaap Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
2468000 usd
CY2024Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5538000 usd
CY2023Q2 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
-2014000 usd
CY2024Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
356712000 usd
CY2023Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
282081000 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
9384000 usd
CY2023Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8536000 usd
CY2024Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
347328000 usd
CY2023Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
273545000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
192398000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
198418000 usd
CY2024Q2 rmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
22843000 usd
CY2023Q2 rmd Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
20501000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
7857000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
12302000 usd
CY2024Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
223098000 usd
CY2023Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
231221000 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
124230000 usd
CY2023Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
42324000 usd
CY2022 us-gaap Income Tax Holiday Aggregate Dollar Amount
IncomeTaxHolidayAggregateDollarAmount
38000000.0 usd
CY2022 us-gaap Income Tax Holiday Income Tax Benefits Per Share
IncomeTaxHolidayIncomeTaxBenefitsPerShare
0.26
CY2024Q2 us-gaap Undistributed Earnings Of Foreign Subsidiaries
UndistributedEarningsOfForeignSubsidiaries
4100000000 usd
CY2024 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4685297000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4222993000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3578127000 usd
CY2023 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
165156000 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
159609000 usd
CY2024 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4685297000 usd
CY2023 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4222993000 usd
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3578127000 usd
CY2024Q2 us-gaap Noncurrent Assets
NoncurrentAssets
548025000 usd
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
537856000 usd
CY2022Q2 rmd Number Of Patents
NumberOfPatents
7 patent
CY2023Q4 rmd Number Of Patents
NumberOfPatents
3 patent
CY2024 rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
206700000 usd
CY2023 rmd Receivables Sold With Limited Recourse
ReceivablesSoldWithLimitedRecourse
181200000 usd
CY2024Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
35800000 usd
CY2024 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
800000 usd
CY2023Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
32600000 usd
CY2023 us-gaap Loss Contingency Accrual Provision
LossContingencyAccrualProvision
600000 usd
CY2024Q2 us-gaap Purchase Obligation
PurchaseObligation
1023088000 usd
CY2024Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
845432000 usd
CY2024Q2 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
113067000 usd
CY2024Q2 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
24125000 usd
CY2024Q2 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
3709000 usd
CY2024Q2 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
1675000 usd
CY2024Q2 us-gaap Purchase Obligation Due After Fifth Year
PurchaseObligationDueAfterFifthYear
35080000 usd
CY2024Q2 us-gaap Derivative Assets
DerivativeAssets
2432000 usd
CY2023Q2 us-gaap Derivative Assets
DerivativeAssets
2405000 usd
CY2024Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
36538000 usd
CY2023Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
70699000 usd
CY2024 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-4149000 usd
CY2023 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-4204000 usd
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
2809000 usd
CY2024 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
10900000 usd
CY2022 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1900000 usd
CY2024 us-gaap Restructuring Charges
RestructuringCharges
64200000 usd
CY2024Q2 us-gaap Restructuring Reserve
RestructuringReserve
0 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
9200000 usd
CY2023 us-gaap Restructuring Charges
RestructuringCharges
9200000 usd
CY2023Q2 us-gaap Restructuring Reserve
RestructuringReserve
7800000 usd
CY2022 us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024 ecd Insider Trd Policies Proc Adopted Flag
InsiderTrdPoliciesProcAdoptedFlag
true

Files In Submission

Name View Source Status
0000943819-24-000013-index-headers.html Edgar Link pending
0000943819-24-000013-index.html Edgar Link pending
0000943819-24-000013.txt Edgar Link pending
0000943819-24-000013-xbrl.zip Edgar Link pending
ex311-ceocertificationq4fy.htm Edgar Link pending
ex312-cfocertificationq4fy.htm Edgar Link pending
ex321-ceoandcfocertificati.htm Edgar Link pending
exhibit105-deferredcompens.htm Edgar Link pending
exhibit19-resmedinsidertra.htm Edgar Link pending
exhibit211-subsidiariesq4f.htm Edgar Link pending
exhibit231-auditorconsentq.htm Edgar Link pending
exhibit42-descriptionofres.htm Edgar Link pending
exhibit97-resmedclawbackpo.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_01.jpg Edgar Link pending
image_01a.jpg Edgar Link pending
image_03.jpg Edgar Link pending
image_0a.jpg Edgar Link pending
image_1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
report.css Edgar Link pending
rmd-20240630.htm Edgar Link pending
rmd-20240630.xsd Edgar Link pending
rmd-20240630_g1.jpg Edgar Link pending
Show.js Edgar Link pending
rmd-20240630_cal.xml Edgar Link unprocessable
rmd-20240630_def.xml Edgar Link unprocessable
rmd-20240630_lab.xml Edgar Link unprocessable
rmd-20240630_pre.xml Edgar Link unprocessable
rmd-20240630_htm.xml Edgar Link completed